4.6 Article

The human IFN-inducible p53 target gene TRIM22 colocalizes with the centrosome independently of cell cycle phase

期刊

EXPERIMENTAL CELL RESEARCH
卷 316, 期 4, 页码 568-579

出版社

ELSEVIER INC
DOI: 10.1016/j.yexcr.2009.12.007

关键词

TRIM22; Staf50; Centrosome; p53; IFN

资金

  1. Swedish Cancer Foundation
  2. Swedish Research Council
  3. Swedish Childhood Cancer Foundation
  4. Crafoord Foundation
  5. Gunnar Nilsson Cancer Foundation
  6. Mrs. Berta Kamprad Foundation for Cancer Research

向作者/读者索取更多资源

TRIM22 (Staf50), a member of the TRIM protein family, is an interferon (IFN)-inducible protein as well as a p53 target gene. The function of TRIM22 is largely unknown, but TRIM22 is suggested to play a role in viral defense by restriction of viral replication. In addition, TRIM22 may function as a ubiquitin E3 ligase. In contrast to previous reports showing solely cytoplasmic localization of exogenous TRIM22, we report here that endogenous TRIM22 is localized to both nucleus and cytosol in primary human mononuclear cells, as well as in the human osteosarcoma cell line U2OS. Moreover, we demonstrate a colocalization of TRIM22 with the centrosomes in primary cells as well as in U2OS cells, and show that this colocalization is independent of cell cycle phase. Additionally, our data suggest the colocalization with centrosomes to be independent on the microtubule network. Given that some Viral protein assembly takes place in the close vicinity of the centrosome, our data suggest that important functions of TRIM22 Such as regulation of viral replication and protein degradation may take place in the centrosome. However, further studies are warranted to certify this notion. (C) 2009 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据